Caption Management, LLC Amgen Inc Put Options Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2.63 Million - $3.19 Million	10,000 New	10,000 $3.12 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $26.8 Million - $31.7 Million	125,000 New	125,000 $27.8 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.18 Million - $2.76 Million	9,500 New	9,500 $2.5 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $212,270 - $248,700	-1,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $23.1 Million - $25.7 Million	-99,000 Reduced 99.0%	1,000 $244,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $22.2 Million - $25.9 Million	100,000 New	100,000 $24.9 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $23.5 Million - $26.1 Million	-100,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $19.8 Million - $24.3 Million	100,000 New	100,000 $23.6 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $45.5 Million - $54.5 Million	-261,300 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $43.6 Million - $51.1 Million	261,300 New	261,300 $48.2 Million

3,073

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.